Last reviewed · How we verify

NCT07306442

VR for Pain & Sleep in Burn Patients: A RCT

Completed NA Last updated 29 December 2025
What this trial tests

NA trial testing Virtual Reality Distraction in Burns in 60 participants. Completed in 1 June 2025.

Timeline
1 January 2025
Primary endpoint
1 June 2025
1 June 2025

Quick facts

Lead sponsorAbadan University of Medical Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date1 January 2025
Primary completion1 June 2025
Estimated completion1 June 2025
Sites1 location across Iran

Drugs / interventions tested

Conditions studied

Sponsor

Abadan University of Medical Sciences

Who can join

Adults 18 to 60, any sex, with Burns or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate whether virtual reality (VR) can reduce pain and improve sleep quality during wound dressing changes in burn patients with 25-60% total body surface area (TBSA) burns, compared to standard care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual Reality Distraction

Trials testing the same drug.

Other recruiting trials for Burns

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07306442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing